A strong week for data readouts: Clinical Report

In a week with rich in positive clinical readouts, three companies saw their share prices more than double — two of them on obesity data.

Capricor Therapeutics Inc. (NASDAQ:CAPR) was the biggest mover, rising 371% to a market cap of over $1.3 billion on Phase III data that shore up a resubmission of deramiocel to FDA to treat cardiomyopathy associated with Duchenne muscular dystrophy (DMD). ...